| 000 | 01542 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250513144524.0 | ||
| 264 | 0 | _c19980708 | |
| 008 | 199807s 0 0 eng d | ||
| 022 | _a0041-1345 | ||
| 024 | 7 |
_a10.1016/s0041-1345(98)00202-4 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aIsenberg, A | |
| 245 | 0 | 0 |
_aSelective CellCept therapy in high-risk renal transplant recipients. _h[electronic resource] |
| 260 |
_bTransplantation proceedings _cJun 1998 |
||
| 300 |
_a1188-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAzathioprine _xtherapeutic use |
| 650 | 0 | 4 |
_aCyclosporine _xtherapeutic use |
| 650 | 0 | 4 | _aDiabetes Mellitus, Type 1 |
| 650 | 0 | 4 |
_aDiabetic Nephropathies _xsurgery |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 |
_aGraft Rejection _xprevention & control |
| 650 | 0 | 4 | _aGraft Survival |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aKidney Transplantation _ximmunology |
| 650 | 0 | 4 |
_aMycophenolic Acid _xanalogs & derivatives |
| 650 | 0 | 4 |
_aPostoperative Complications _xepidemiology |
| 650 | 0 | 4 |
_aPrednisone _xtherapeutic use |
| 650 | 0 | 4 | _aReoperation |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aSurvival Rate |
| 700 | 1 | _aSingh, T P | |
| 700 | 1 | _aShen, G K | |
| 700 | 1 | _aFreed, B M | |
| 700 | 1 | _aConti, D J | |
| 773 | 0 |
_tTransplantation proceedings _gvol. 30 _gno. 4 _gp. 1188-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0041-1345(98)00202-4 _zAvailable from publisher's website |
| 999 |
_c9602761 _d9602761 |
||